{
  "guid": "gid://art19-episode-locator/V0/um-voEoD3tkp4lXskv0XjMRx1SWCrt6uBNqKUUkY3JI",
  "title": "The Vaccine Trust Problem",
  "description": "<p>Public health officials and private researchers have vowed to develop a coronavirus vaccine in record time. But could that rush backfire? Guest: <a href=\"https://www.nytimes.com/by/jan-hoffman\" target=\"_blank\">Jan Hoffman</a>, a health reporter for The New York Times. For more information on today’s episode, visit <a href=\"http://nytimes.com/thedaily\" target=\"_blank\">nytimes.com/thedaily </a></p><p>Background reading: </p><ul><li>Billions of dollars are being poured into developing a coronavirus vaccine, but the rapid timetable may be<a href=\"https://www.nytimes.com/2020/07/18/health/coronavirus-anti-vaccine.html\" target=\"_blank\"> creating even more vaccine-hesitant patients</a>.</li><li>Three vaccine developers report that early trials showed promising results with minimal side effects, but <a href=\"https://www.nytimes.com/2020/07/20/world/covid-coronavirus-vaccine.html\" target=\"_blank\">one researcher cautioned</a>, “There is still a long way to go.”</li></ul>\n",
  "pubDate": "Tue, 21 Jul 2020 09:54:19 +0000",
  "author": "thedaily@nytimes.com (The New York Times)",
  "link": "https://www.nytimes.com/the-daily",
  "content:encoded": "<p>Public health officials and private researchers have vowed to develop a coronavirus vaccine in record time. But could that rush backfire? Guest: <a href=\"https://www.nytimes.com/by/jan-hoffman\" target=\"_blank\">Jan Hoffman</a>, a health reporter for The New York Times. For more information on today’s episode, visit <a href=\"http://nytimes.com/thedaily\" target=\"_blank\">nytimes.com/thedaily </a></p><p>Background reading: </p><ul><li>Billions of dollars are being poured into developing a coronavirus vaccine, but the rapid timetable may be<a href=\"https://www.nytimes.com/2020/07/18/health/coronavirus-anti-vaccine.html\" target=\"_blank\"> creating even more vaccine-hesitant patients</a>.</li><li>Three vaccine developers report that early trials showed promising results with minimal side effects, but <a href=\"https://www.nytimes.com/2020/07/20/world/covid-coronavirus-vaccine.html\" target=\"_blank\">one researcher cautioned</a>, “There is still a long way to go.”</li></ul>\n",
  "enclosure": "",
  "itunes:title": "The Vaccine Trust Problem",
  "itunes:author": "The New York Times",
  "itunes:image": "",
  "itunes:duration": "00:27:45",
  "itunes:summary": "Public health officials and private researchers have vowed to develop a coronavirus vaccine in record time. But could that rush backfire? Guest: Jan Hoffman, a health reporter for The New York Times. For more information on today’s episode, visit nytimes.com/thedaily \n\nBackground reading: Billions of dollars are being poured into developing a coronavirus vaccine, but the rapid timetable may be creating even more vaccine-hesitant patients.Three vaccine developers report that early trials showed promising results with minimal side effects, but one researcher cautioned, “There is still a long way to go.”",
  "itunes:subtitle": "Public health officials and private researchers have vowed to develop a coronavirus vaccine in record time. But could that rush backfire? Guest: Jan Hoffman, a health reporter for The New York Times. For more information on today’s episode, visit nytimes.com/thedaily \n\nBackground reading: Billions of dollars are being poured into developing a coronavirus vaccine, but the rapid timetable may be creating even more vaccine-hesitant patients.Three vaccine developers report that early trials showed promising results with minimal side effects, but one researcher cautioned, “There is still a long way to go.”",
  "itunes:explicit": "no",
  "itunes:episodeType": "full"
}